The Pennant Group, Inc. (NASDAQ:PNTG) Director Joanne Stringfield Sells 665 Shares

The Pennant Group, Inc. (NASDAQ:PNTGGet Free Report) Director Joanne Stringfield sold 665 shares of The Pennant Group stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $27.88, for a total transaction of $18,540.20. Following the transaction, the director now directly owns 29,040 shares in the company, valued at approximately $809,635.20. This trade represents a 2.24 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

The Pennant Group Stock Up 4.8 %

Shares of The Pennant Group stock opened at $27.89 on Wednesday. The Pennant Group, Inc. has a 1-year low of $14.84 and a 1-year high of $37.13. The company has a market capitalization of $958.02 million, a PE ratio of 41.02, a P/E/G ratio of 2.35 and a beta of 1.92. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The business has a 50-day moving average of $28.04 and a 200-day moving average of $30.96.

Analysts Set New Price Targets

Several equities analysts recently weighed in on PNTG shares. Truist Financial reduced their target price on shares of The Pennant Group from $38.00 to $32.00 and set a “hold” rating on the stock in a report on Monday, January 6th. Royal Bank of Canada boosted their price objective on The Pennant Group from $26.00 to $38.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 23rd. Stephens reiterated an “overweight” rating and issued a $40.00 target price on shares of The Pennant Group in a research note on Wednesday, October 9th. Oppenheimer boosted their price target on The Pennant Group from $34.00 to $37.00 and gave the stock an “outperform” rating in a research report on Friday, November 8th. Finally, Wells Fargo & Company assumed coverage on shares of The Pennant Group in a research report on Thursday, December 19th. They issued an “equal weight” rating and a $33.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, The Pennant Group currently has a consensus rating of “Moderate Buy” and an average price target of $36.00.

Read Our Latest Analysis on PNTG

Institutional Investors Weigh In On The Pennant Group

A number of hedge funds have recently bought and sold shares of the business. Creative Planning raised its position in shares of The Pennant Group by 2.0% in the 2nd quarter. Creative Planning now owns 19,152 shares of the company’s stock valued at $444,000 after purchasing an additional 373 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in The Pennant Group by 4.4% in the second quarter. The Manufacturers Life Insurance Company now owns 11,227 shares of the company’s stock valued at $260,000 after acquiring an additional 471 shares in the last quarter. D.A. Davidson & CO. raised its holdings in The Pennant Group by 4.0% in the third quarter. D.A. Davidson & CO. now owns 15,126 shares of the company’s stock valued at $540,000 after acquiring an additional 575 shares in the last quarter. Quarry LP boosted its stake in The Pennant Group by 371.6% during the 3rd quarter. Quarry LP now owns 1,014 shares of the company’s stock valued at $36,000 after acquiring an additional 799 shares during the last quarter. Finally, Principal Financial Group Inc. grew its holdings in The Pennant Group by 10.9% during the 4th quarter. Principal Financial Group Inc. now owns 14,000 shares of the company’s stock worth $371,000 after acquiring an additional 1,374 shares in the last quarter. Institutional investors and hedge funds own 85.88% of the company’s stock.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Further Reading

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.